• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Lungpacer Medical

Lungpacer Medical raises nearly $16M

January 6, 2021 By Sean Whooley

Lungpacer Medical filed an SEC Form D earlier this week to confirm the sale of nearly $16 million in an equity financing. Vancouver, Canada-based Lungpacer develops a diaphragm pacing therapy system (DPTS) to assist in weaning patients off mechanical ventilation who are determined by a healthcare provider to be at high risk of weaning failure. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Respiratory Tagged With: Lungpacer Medical

FDA grants EUA to Lungpacer for diaphragm pacing system

April 23, 2020 By Sean Whooley

Lungpacer Medical announced last week that it received FDA emergency use authorization (EUA) for use of its diaphragm pacing therapy system (DPTS) in some COVID-19 cases. The Vancouver, Canada–based company designed its DPTS to assist in weaning patients who are determined by a healthcare provider to be at high risk of weaning failure. In a […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory Tagged With: coronavirus, COVID-19, FDA, Lungpacer Medical

Lungpacer Medical hits the FDA fast track with phrenic nerve pacer

May 11, 2016 By Brad Perriello

Lungpacer Medical said it won an expedited access pathway designation from the FDA for the diaphragm pacing system it’s developing to treat patients who can’t be weaned from mechanical ventilation. The Lungpacer DPS device is a neurostimulation system designed to exercise and strengthen the diaphragm via the temporary, transcatheter stimulation of the phrenic nerve. The FDA’s […]

Filed Under: Food & Drug Administration (FDA), Neuromodulation/Neurostimulation, Regulatory/Compliance, Respiratory Tagged With: Expedited Access Program (EAP), Lungpacer Medical

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS